Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.

Journal of pediatric hematology/oncology - 1 Aug 2018

Rastogi Neha, Abraham Roshini S, Chadha Ritu, Thakkar Dhwanee, Kohli Shruti, Nivargi Sagar, Prakash Yadav Satya

Abstract excerpt

Emberger syndrome with underlying guanine-adenine-thymine-adenine 2 (GATA2) mutation is a rare disorder and very few successful nonmyeloablative allogeneic hematopoietic stem cell transplants (HSCTs) have been reported. We report a case of Emberger syndrome with GATA2 mutation in a 9-year-old girl who presented with congenital sensorineural deafness, warts, lymphedema, and Myelodysplastic syndrome. Her sister had...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to Cyclophosphamide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GATA2 Transcription Factor

Share to Mycophenolic Acid

Share to Skin Diseases

Share to Transplantation Conditioning

Share to Vidarabine

Share to Whole-Body Irradiation

Source

Identifiers

PMID: 29189513
DOI: 10.1097/MPH.0000000000000995

Genes

GATA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.PMID 29189513Read ↗

Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 MutationsSemantic proximity Read ↗

Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS.Semantic proximity Read ↗

A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene.Semantic proximity Read ↗

Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.Semantic proximity Read ↗

Successful Hematopoietic Stem Cell Transplantation in a Patient with Complete IFN-γ Receptor 2 Deficiency: a Case Report and Literature Review.Semantic proximity Read ↗

Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.Semantic proximity Read ↗

Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndromeSemantic proximity Read ↗

First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation.Semantic proximity Read ↗

Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II.Semantic proximity Read ↗

Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.Semantic proximity Read ↗

Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.